COLLABORATIONS
› Collaborations » Partnering Strategy | Process & Media development | Our Partners

Our Partners

Hitachi Chemical
Hitachi Chemical has recently obtained the license for Accellta's latest media which is devoid of human/animal derived components and comprised only of artificially synthesized substances, offering a high level of safety that is key to the success of regenerative medicine.

STEMCELL Technologies
Accellta granted exclusive worldwide rights for micro-carrier free stem cells suspension culture to STEMCELL Technologies.

Ajinomoto Co.
Accellta has granted worldwide non-exclusive rights to Ajinomoto Co. Inc. for manufacturing and distribution of proprietary cell culture medium and ancillary products and methods.

EMD Millipore
Accellta has granted worldwide non-exclusive rights to EMD Millipore for manufacturing and distribution of proprietary cell culture medium and ancillary products and methods.